Evidence map›Paper›PMID 41884162›Full record

ArticleJournal of inflammation research2026

Knowledge Mapping of CircRNAs in AS Research from 2010 to 2025: Spotlight on Lipid Metabolism, Pyroptosis and Exosomes.

Kunjun Wu, Shipei He, Yuyan Shen, Jiandi Li, Bin Li, Guoqiang Chen, Yixun Lei, Gang Chen, Qi Li, Mingjie Li

Abstract read
In one paragraph

Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kunjun Wu *Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Shipei He *Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Yuyan ShenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Jiandi LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Bin LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Guoqiang ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Yixun LeiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Gang ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.ORCID 0000-0003-2402-2987
Qi Li *Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.
Mingjie Li *Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China.ORCID 0000-0003-1958-1303

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atherosclerosis (AS) is the leading cause of death from cardiovascular disease worldwide, involving complex inflammatory, molecular and cellular pathways as well as intercellular cross-talk. CircRNAs are highly stable, circular non-coding RNAs that function by acting as miRNA sponges, regulating transcription, and influencing protein translation. In AS research, CircRNAs have turned the spotlight onto a promising new target with significant therapeutic potential. This study aimed to elucidate academic landscape, reveal active topics and future research focus of CircRNAs in AS research. Methods: Publications on CircRNAs in AS research were retrieved from Web of Science Core Collection (WoSCC). The bibliometric tools, including R, VOSviewer and Citespace, were used to conduct a scientometric analysis of 225 relevant studies. Results: This study identifies China as the primary research nations in the field of CircRNAs in AS research. However, attention must still be paid to the striking imbalance between productivity and deserved impact. The majority of current research is conducted using in vitro models. However, in vivo experiments are urgently needed to provide additional evidence for the inconclusive results obtained in vitro. The lipid infiltration theory, particularly the role of CircRNAs in regulating macrophage cholesterol efflux, has become a new research entry point for the treatment of AS. In addition, this study also identified pyroptosis and exosomes as future research focus in the field of CircRNAs in AS research. Conclusion: This bibliometric analysis synthesises the extensive evidence on CircRNAs in AS research and provides insights to guide future scientific work in this field.

Indexed as

atherosclerosisbibliometricCircRNAexosomespyroptosis

Identifiers

PMID41884162
PMCPMC13012555

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.